The latest cancer drugs news
Browsing: Cancer Drug News
SU2C research leads to FDA approval of new first-line treatment for colorectal cancer
The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with…
Lithuanian researchers propose combination of methods to improve anticancer drug delivery
Application of low-intensity pulsed ultrasound in combination with microbubbles might enhance the delivery of chemotherapy…
New drug inhibits the growth of cancer cells
A newly developed compound starves cancer cells by attacking their “power plants” — the so-called…
Common anti-diarrhoea drug can induce death of aggressive brain cancer cells
A common drug that is usually prescribed to treat diarrhoea may also be a powerful weapon…
Protein twist and squeeze confers cancer drug resistance
In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University’s Institute for Integrated Cell-Material Sciences…
FDA approves pralsetinib for RET-altered thyroid cancers
On December 1, 2020, the Food and Drug Administration approved pralsetinib for adult and paediatric…
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…
FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers
On October 26 and November 6, 2020, the Food and Drug Administration approved the liquid…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
NCRI 2020: New bowel cancer model uncovering how it avoids immunotherapy drug
Scientists at The Institute of Cancer Research, London, UK, have developed a complex model system…